Key result
Delayed captopril prevents LV dilation and improves EF versus control in post-MI mice.
Why the study?
The mechanisms underlying how captopril improves post-infarction survival remain inadequately understood due to diverse signaling effects over time, prompting investigation into its role in late-stage post-MI remodelling.
Does delayed captopril treatment improve post-infarction remodeling and cardiac function in a mouse model of myocardial infarction?
Does delayed captopril treatment improve post-infarction remodeling and cardiac function in a mouse model of myocardial infarction?
Delayed captopril treatment improves post-infarction cardiac remodeling and vascular density in mice, validating the use of combined echocardiography and 3D light sheet imaging for preclinical cardiovascular research.
Angiotensin converting enzyme inhibitors, among them captopril, improve survival following myocardial infarction (MI). The mechanisms of captopril action remain inadequately understood due to its diverse effects on multiple signalling pathways at different time periods following MI. Here we aimed to establish the role of captopril in late-stage post-MI remodelling. Left anterior descending artery (LAD) ligation or sham surgery was carried out in male C57BL/6J mice. Seven days post-surgery LAD ligated mice were allocated to daily vehicle or captopril treatment continued over four weeks. To provide comprehensive characterization of the changes in mouse heart following MI a 3D light sheet imaging method was established together with automated image analysis workflow. The combination of echocardiography and light sheet imaging enabled to assess cardiac function and the underlying morphological changes. We show that delayed captopril treatment does not affect infarct size but prevents left ventricle dilation and hypertrophy, resulting in improved ejection fraction. Quantification of lectin perfused blood vessels showed improved vascular density in the infarct border zone in captopril treated mice in comparison to vehicle dosed control mice. These results validate the applicability of combined echocardiographic and light sheet assessment of drug mode of action in preclinical cardiovascular research.
No takes yet. Share an insight, caveat, or question.
Roostalu et al. (2021) studied Myocardial infarction. Captopril vs. Vehicle was evaluated on Cardiac function and morphological changes (infarct size, left ventricle dilation, hypertrophy, ejection fraction). Delayed captopril treatment in post-MI mice prevented left ventricle dilation and hypertrophy, improved ejection fraction, and increased vascular density compared to vehicle control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: